NO174110C - Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet - Google Patents

Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet

Info

Publication number
NO174110C
NO174110C NO885053A NO885053A NO174110C NO 174110 C NO174110 C NO 174110C NO 885053 A NO885053 A NO 885053A NO 885053 A NO885053 A NO 885053A NO 174110 C NO174110 C NO 174110C
Authority
NO
Norway
Prior art keywords
antibody
vitro
diagnosis
specific
inflammatory diseases
Prior art date
Application number
NO885053A
Other languages
English (en)
Norwegian (no)
Other versions
NO885053L (no
NO174110B (no
NO885053D0 (no
Inventor
Atsushi Kawamura
Isao Suda
Kinji Takada
Masayoshi Ito
Yoshiyasu Shitori
Original Assignee
Kanto Ishi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanto Ishi Pharma Co Ltd filed Critical Kanto Ishi Pharma Co Ltd
Publication of NO885053D0 publication Critical patent/NO885053D0/no
Publication of NO885053L publication Critical patent/NO885053L/no
Publication of NO174110B publication Critical patent/NO174110B/no
Publication of NO174110C publication Critical patent/NO174110C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO885053A 1987-11-13 1988-11-11 Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet NO174110C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28711987 1987-11-13
JP63026848A JPH02486A (ja) 1987-11-13 1988-02-08 遊離ｎ−アセチルノイラミン酸を認識するモノクローナル抗体

Publications (4)

Publication Number Publication Date
NO885053D0 NO885053D0 (no) 1988-11-11
NO885053L NO885053L (no) 1989-05-16
NO174110B NO174110B (no) 1993-12-06
NO174110C true NO174110C (no) 1994-03-16

Family

ID=26364692

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885053A NO174110C (no) 1987-11-13 1988-11-11 Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet

Country Status (13)

Country Link
US (1) US5158886A (fi)
EP (1) EP0316818B1 (fi)
JP (1) JPH02486A (fi)
KR (1) KR960004855B1 (fi)
AU (1) AU614553B2 (fi)
CA (1) CA1336763C (fi)
DE (1) DE3881344T2 (fi)
ES (1) ES2054772T3 (fi)
FI (1) FI90989C (fi)
HU (1) HU204897B (fi)
IL (1) IL88322A (fi)
NO (1) NO174110C (fi)
NZ (1) NZ226937A (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03242553A (ja) * 1990-02-19 1991-10-29 Mect Corp エピシアロ複合糖質を含む製剤
US7682794B2 (en) 2003-07-15 2010-03-23 The Regents Of The University Of California Methods for detecting and analyzing N-glycolylneuraminic acid (Neu5Gc) in biological materials
CN100401753C (zh) * 2004-07-20 2008-07-09 上海乐金广电电子有限公司 数码tv接收用智能天线控制系统
WO2013151649A1 (en) 2012-04-04 2013-10-10 Sialix Inc Glycan-interacting compounds
FI3218005T3 (fi) 2014-11-12 2023-03-31 Seagen Inc Glykaanin kanssa vuorovaikutteisia yhdisteitä ja käyttömenetelmiä
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
CA3002097A1 (en) 2015-11-12 2017-05-18 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
US11401330B2 (en) 2016-11-17 2022-08-02 Seagen Inc. Glycan-interacting compounds and methods of use
SG11201907889YA (en) 2017-03-03 2019-09-27 Seattle Genetics Inc Glycan-interacting compounds and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164798A (ja) * 1983-03-09 1984-09-17 Rikagaku Kenkyusho シアル酸含有糖脂質誘導体

Also Published As

Publication number Publication date
DE3881344D1 (de) 1993-07-01
EP0316818A3 (en) 1990-08-22
ES2054772T3 (es) 1994-08-16
JPH02486A (ja) 1990-01-05
NO885053L (no) 1989-05-16
DE3881344T2 (de) 1993-09-09
HU204897B (en) 1992-02-28
FI885169A0 (fi) 1988-11-10
NO174110B (no) 1993-12-06
KR960004855B1 (ko) 1996-04-16
FI90989C (fi) 1994-04-25
KR890007755A (ko) 1989-07-05
NO885053D0 (no) 1988-11-11
US5158886A (en) 1992-10-27
NZ226937A (en) 1991-02-26
AU614553B2 (en) 1991-09-05
FI90989B (fi) 1994-01-14
HUT48676A (en) 1989-06-28
AU2498288A (en) 1989-05-18
EP0316818A2 (en) 1989-05-24
FI885169A (fi) 1989-05-14
IL88322A (en) 1994-05-30
CA1336763C (en) 1995-08-22
EP0316818B1 (en) 1993-05-26

Similar Documents

Publication Publication Date Title
ES2061730T3 (es) Nuevos anticuerpos.
DE3586440D1 (de) Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper.
IT8319234A0 (it) Procedimento per la produzione di anticorpi monoclonali umani.
EP0314402A3 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
JPS6434291A (en) Polynucleotide sequence, its production, polypeptide, fragment, antibody, polynucleotide specimen, diagnosis and estimation of malignant disease and examination of presence or absence of factor of malignant disease
IT1245748B (it) Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego
IT1150682B (it) Procedimento per la produzione di sostanze prodotte da cellule,particolarmente di anticorpi e simili
NO870770L (no) FremgangsmŸte for fremstilling av monoklonale antistoffer.
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
NO174110C (no) Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet
EP0232871A3 (en) Human monoclonal antibody, hybridoma producing the same and its use
ES557072A0 (es) Procedimiento para la obtencion de lineas celulares de hibridoma
DK127686D0 (da) Monoklonale antistoffer mod atriale, natriuretiske peptider hos mennesker
DE3886545T2 (de) Monoklonale human-antikörper, spezifisch für rh(d).
ATE58397T1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
EP0143367A3 (en) Method for production of monoclonal antibodies for cancer diagnosis and therapy
WO1986002651A3 (en) Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells
GR3015489T3 (en) Monoclonal antibodies and process for the diagnosis of phytophtora infections.
IT8967049A0 (it) Anticorpo umano monoclonale composizione terapeutica che lo contiene linea cellulare capace di produrre l anticorpo procedimento per la suaproduzione
IT7830722A0 (it) Metodo di prova in vitro per la diagnosi di tumori maligni.
ITMI921385A1 (it) Anticorpi monoclonali e corredi diagnostici che li contengono per la diagnosi ed il monitoraggio di malattie infiammatorie ed
NO874799D0 (no) Fremgangsmaate for fremstilling av monoklonale antistoffer ved dyrking av hybridom-cellelinjen lym-2.
ITRM980795A0 (it) Anticorpi monoclonali per la diagnosi di patologie da fitoplasmi del melo, metodo diagnostico e kit relativo
NO893093D0 (no) Teknikk for fremstilling av fullblodproeve.
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same